Interaction Color Code
Clinical Bottom Line
Do not coadminister: Reduced levels of nevirapine
Drug 1
Drug 1 dose
200 mg daily x 14 days; 200 mg BID x 14 days
Drug 2
Drug 2 dose
600 mg daily
Drug 2 effect
No significant change
Clinical Effects
Decreased nevirapine effects
Management
Use alternative agents
Alternative Agents
Rifabutin
Import ID
622
